The storied success of copyright’s flagship drug has undeniably transformed the drug landscape. However, putting money in companies heavily reliant on biosimilars and the diminishing patent exclusivity surrounding this iconic medication presents a considerable degree of peril . While established pharma firms may still profit from related products

A thorough industry assessment is critical for identifying the current forces at play. This study delves into major factors influencing the competitive space, from developing technologies and changing consumer preferences to governmental hurdles and economic uncertainties. We’ll evaluate the aggregate outlook, including potential growth areas, da